CME Article Brugada pattern masking anterior myocardial infarction

Similar documents
Are there low risk patients in Brugada syndrome?

Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation

The Brugada Syndrome: An Easily Identified and Preventable Cause of Sudden Cardiac Death

Brugada Syndrome: Age is just a number

A case of Brugada syndrome coexisting with vasospastic angina: Caution should be taken when using calcium channel blockers

P. Brugada 1, R. Brugada 2 and J. Brugada 3. Introduction. U.S.A.; 3 Unitat d Arritmias, Hospital Clinic, Barcelona, Spain

Optimal management of Brugada syndrome

Corporate Medical Policy

Case Presentation. Asaad Khan University College Hospital Galway Rep of Ireland

ECG Cases and Questions. Ashish Sadhu, MD, FHRS, FACC Electrophysiology/Cardiology

ECGs of structural heart disease: Part I

Myocardial Infarction. Reading Assignment (p66-78 in Outline )

the ECG, 6 mg of intravenous adenosine was administered as a fast bolus through a large bore intravenous cannula in

Low Prevalence of Risk Markers in Cases of Sudden Death Due to Brugada Syndrome

Acute Coronary Syndromes Unstable Angina Non ST segment Elevation MI (NSTEMI) ST segment Elevation MI (STEMI)

J Wave Syndromes. Osama Diab Lecturer of Cardiology Ain Shams University

All About STEMIs. Presented By: Brittney Urvand, RN, BSN, CCCC. Essentia Health Fargo Cardiovascular Program Manager.

Electrophysiologic investigation in Brugada syndrome

INTRODUCTION. left ventricular non-compaction is a sporadic or familial cardiomyopathy characterized by

1 Fq-ii I - I I...L w. husband on the morning of her admission. Her symptoms

Electrocardiographic T wave abnormalities

15 th Sukaman Memorial Lecture ST Segment Elevation: New Electrocardiographic Insights in 2014

Considerations about the polemic J point location

Case Report. Faculty of Medicine, Oita University 2 Department of Cardiology, Hakuaikai Hospital

FANS ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) Investigation Protocol

_FT 4. _Ci4 - ;,..., r. _ L.1_4±J-1 +.1_77 di _-_,..i , lt.! -7H :-,-...i-2 Litt drri "94. _Ia. :7...-t. ' ; r., r - .J...

When the rhythm of life is disturbed

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !

Case Report A Case of Isolated Left Ventricular Noncompaction with Basal ECG-Tracing Strongly Suggestive for Type-2 Brugada Syndrome

Appearance of J wave in the inferolateral leads and ventricular fibrillation provoked by mild hypothermia in a patient with Brugada syndrome

J-wave syndromes: update on ventricular fibrillation mechanisms

Atrial Fibrillation and Brugada Syndrome

A 33 year old man after sudden cardiac arrest as a first manifestation of Brugada syndrome (RCD code: V 1A.1)

The Electrophysiologic Mechanism of ST-Segment Elevation in Brugada Syndrome

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

Automatic External Defibrillators

Title: Automatic External Defibrillators Division: Medical Management Department: Utilization Management

ICD in a young patient with syncope

The Fundamentals of 12 Lead EKG. ECG Recording. J Point. Reviewing the Cardiac Conductive System. Dr. E. Joe Sasin, MD Rusty Powers, NRP

A case of convulsion: Brugada syndrome

Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation?

The Early Repolarization ECG Pattern An Update

MICS OF MYOCARDIAL ISCHEMIA AND INFARCTION REVISED FOR LAS VEGAS

Current ECG interpretation guidelines in the screening of athletes

Other 12-Lead ECG Findings

at least 4 8 hours per week

PECTUS EXCAVATUM WITH SPONTANEOUS TYPE 1 ECG BRUGADA PATTERN OR BRUGADA LIKE PHENOTYPE: ANOTHER BRUGADA ECG PHENOCOPY

myocardial infarction

The Brugada syndrome is an arrhythmogenic disease

J Wave Syndrome: Clinical Diagnosis, Risk Stratification And Treatment Kamal K Sethi,Kabir Sethi,Surendra K Chutani

Patient Resources: Cardiac Channelopathies

SIMPLY ECGs. Dr William Dooley

Invasive Risk Stratification: When is it needed?

Type 1 electrocardiographic burden is increased in symptomatic patients with Brugada syndrome

Short QT Syndrome: Pharmacological Treatment

Original Article Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy

Clinical profile and genetic basis of Brugada syndrome in the Chinese population

Ventricular Arrhythmia Induced by Sodium Channel Blocker in Patients With Brugada Syndrome

Masqueraders of STEMI

Heart Rhythm Disorders. How do you quantify risk?

Διαχείρηση Ασυμπτωματικού ασθενούς με ΗΚΓ τύπου Brugada

The ajmaline challenge in Brugada syndrome: Diagnostic impact, safety, and recommended protocol

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

MEDICAL POLICY POLICY TITLE T-WAVE ALTERNANS TESTING POLICY NUMBER MP

Dr Wilde, could you please begin by describing the strongest key evidence in support of the depolarisation hypothesis?

Ripolarizzazione precoce.

ACUTE CORONARY SYNDROME

REtrive. REpeat. RElearn Design by. Test-Enhanced Learning based ECG practice E-book

Brugada syndrome is a cardiac disease caused by an

ECG pre-reading manual. Created for the North West Regional EMET training program

Journal of the American College of Cardiology Vol. 40, No. 2, by the American College of Cardiology Foundation ISSN /02/$22.

Quinidine for Brugada syndrome: Panacea or poison?

Name of Presenter: Marwan Refaat, MD

Ripolarizzazione precoce. Torino, 24th October Non così innocente come si pensava

Study methodology for screening candidates to athletes risk

Signal-Averaged Electrocardiography (SAECG)

20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney disease CKD Brugada 5 Brugada Brugada 1

Cardiac Arrest due to Recurrent Ventricular Fibrillation Triggered by Unifocal Ventricular Premature Complexes in a Silent Myocardial Infarction

Clinical Cardiac Electrophysiology

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

12 Lead ECG Interpretation

ECG Workshop. Carolyn Shepherd And Anya Horne UWE Principles of Cardiac Care

ECG Workshop. Nezar Amir

Prevalence and QT Interval of Early Repolarization. in a Hospital-based Population

Arrhythmias (II) Ventricular Arrhythmias. Disclosures

Pearls of the ESC/ERS Guidelines 2015 Channelopathies

Hereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases

Index. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type.

A 19 Year old Woman Admitted to Hospital Confused and Agitated with Intermittent Twitching of her Upper and Lower Limbs

Approximately 5% of patients who experience sudden death

Stage I: Binning Dashboard

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.

Bundle Branch & Fascicular Blocks. Reading Assignment (p53-58 in Outline )

12 Lead Interpretation

Risk Stratification for Asymptomatic Patients With Brugada Syndrome

Left posterior hemiblock (LPH)/

PERMANENT PACEMAKERS AND IMPLANTABLE DEFIBRILLATORS Considerations for intensivists

3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart.

Biventricular Arrhythmogenic Cardiomyopathy: A New Paradigm?

Transcription:

Electrocardiography Series Singapore Med J 2011; 52(9) : 647 CME Article Brugada pattern masking anterior myocardial infarction Seow S C, Omar A R, Hong E C T Cardiology Department, National University Health System, 1E Kent Ridge Road, Fig. 1 ECG taken at presentation shows Brugada Type 1 Pattern. Level 9, NUHS Tower Block, Singapore 119228 Seow SC, MBBS, Omar AR, MBBS, Hong ECT, MBBS, Correspondence to: Dr Seow Swee Chong Tel: (65) 6772 5286 Fax: (65) 6872 2998 Email: swee_chong_ seow@nuhs.edu.sg CLINICAL PRESENTATION A 48-year-old male smoker presented with intermittent chest pain for two days. Described as a pulling sensation that lasted for a few minutes, the most severe episode occurred within the two hours prior to presentation. An electrocardiogram (ECG) was obtained, which was consistent with Brugada Type 1 pattern (Fig. 1). There was no history of syncope or palpitations, or a family history of sudden cardiac death. As the chest pain was atypical for coronary artery disease, the patient was placed under observation while blood samples were sent for cardiac enzymes and troponins. A second ECG obtained one hour later (Fig. 2), however, was consistent with an evolving anterior ST elevation myocardial infarction (STEMI). What is the diagnosis?

Singapore Med J 2011; 52(9) : 648 Fig. 2 Subsequent ECG shows evolving ST elevation myocardial infarction. ECG INTERPRETATION The first ECG (Fig. 1) shows elevation of the J point in leads V1 and V2, with coved-type ST segment elevation. This is associated with T wave inversions, simulating a pseudo-right bundle branch block (RBBB) pattern. However, unlike a true RBBB pattern, there are no prominent S waves in the lateral leads V5 and V6, I Type 1 ECG pattern, demonstrating that the initial ECG features on presentation were not due to the STEMI per se. Electrophysiological study performed three months later showed inducible polymorphic ventricular tachycardia (VT). The patient, however, declined an implantable cardioverter defibrillator (ICD) implant. and avl. These are consistent with a Brugada Type 1 DISCUSSION segment elevations can been seen in leads I and avl, the J point and ST segment elevation in leads V1 3, ECG pattern. On closer examination, very subtle ST Brugada syndrome can present with elevation of as well as ST segment depression in leads II, III and accompanied by T inversion. This can be confused with avf; these findings cannot be accounted for by the Brugada Type 1 pattern alone. In the second ECG (Fig. 2), taken one hour later, a loss of R waves in leads V1 V3 and III is observed. Deep Q waves are forming in these leads, with T wave inversions extending from V1 V4. These T wave inversions are deep and symmetrical, consistent with an evolving myocardial infarction. ST segment elevation is now clearly seen in V1 V4, I and avl. DIAGNOSIS Anterior ST segment elevation myocardial infarction on a background of Brugada Type 1 ECG pattern. CLINICAL COURSE Coronary angiogram revealed tandem lesions in the left anterior descending coronary artery (Fig. 3), which were STEMI; in our case, it masked the findings of an anterior STEMI and led to a delay in primary angioplasty. The findings of ST segment elevation beyond V3 or in other leads, especially with accompanying reciprocal changes (ST segment depression) should alert one to the diagnosis of an acute coronary syndrome. It is important that a STEMI is recognised promptly and revascularisation achieved as quickly as possible, as this has implications on mortality and cardiac function. Three different ECG patterns have been described for Brugada syndrome. In Brugada Type 1 ( coved pattern ) ECG, the elevated ST segment (> 2 mm) is convex and descends to an inverted T wave. Type 2 and Type 3 patterns have a saddle back ST-T wave configuration, with an upright or biphasic T wave (Fig. 4). Brugada syndrome demonstrates autosomal dominant stented. Echocardiogram subsequently showed preserved inheritance with variable expression. Genetic analysis has one month later showed persistence of the Brugada sodium channel, as the cause of Brugada syndrome in left ventricular ejection fraction. Repeat ECG performed implicated SCN5A, a gene encoding a subunit of a cardiac

Singapore Med J 2011; 52(9) : 649 Fig. 3 Coronary angiogram shows the culprit lesions (arrows). Fig. 4 Brugada ECG pattern Types 1, 2 and 3. 18% 30% of families. (1-4) The pathogenesis of the ST segment elevation in Brugada syndrome is not completely understood. Ventricular myocardium comprises at least three electrophysiologically distinct cell types: epicardial, endocardial and M cells. ST segment elevation is believed to be due to an alteration in the action potential in the epicardial and M cells but not in the endocardial cells. (5-7) The resulting dispersion of repolarisation across the ventricular wall, which is most pronounced in the right ventricle, results in a transmural voltage gradient that is manifested as ST segment elevation in leads V1 3. Ventricular arrhythmias may be caused by heterogeneity of the cardiac action potential across the three layers of myocardial cells as well as within the epicardium. Male gender and a family history of sudden cardiac death (SCD) are risk factors for SCD. Patients with a history of cardiac arrest and/or syncope are also at increased risk compared to asymptomatic individuals. (2,8-10) Among asymptomatic patients, the presence of a spontaneous Type 1 ECG pattern (as opposed to only after drug challenge) and inducible ventricular tachyarrhythmia on electrophysiologic testing are markers of increased risk for SCD. (11,12) At present, it is generally agreed that an ICD is indicated in all Brugada syndrome patients with a prior cardiac arrest and in patients with a spontaneous Type 1 ECG plus a history of syncope. Evidence also supports ICD implantation in patients with a history of VT that did not result in cardiac arrest. ABSTRACT A middle-aged male smoker presented with atypical chest pain. Initial electrocardiogram (ECG) showed Brugada Type 1 pattern. Subsequent ECGs demonstrated evolving anterior ST elevation myocardial infarction (STEMI), consistent with the elevated cardiac enzymes. Coronary angiogram showed significant stenoses in the left anterior descending artery, which were stented emergently. In retrospect, subtle changes were noted in the initial ECG, which could have alerted one to the STEMI. However, the presence of a Brugada Type 1 pattern masked the ECG changes of anterior STEMI and made the diagnosis difficult. A discussion of the literature surrounding Brugada syndrome is undertaken, including its clinical features, risk stratification and management. Keywords: Brugada syndrome, electrocardiogram, myocardial infarction, ST elevation Singapore Med J 2011; 52(9): 647 651 REFERENCES 1. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2005; 2:429-40. 2. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002; 105:1342-7. 3. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392:293-6. 4. Priori SG, Napolitano C, Gasparini M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation 2000; 102:2509-15. 5. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999; 100:1660-6.

Singapore Med J 2011; 52(9) : 650 6. Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman BR. The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 1999; 33:5-15. 7. Alings M, Wilde A. Brugada syndrome: clinical data and suggested pathophysiological mechanism. Circulation 1999; 99:666-73. 8. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003; 108:3092-6. 9. Brugada J, Brugada R, Antzelevitch C, et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002; 105:73-8. 10. Eckardt L, Probst V, Smits JP, et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 2005; 111:257-63. 11. Brugada P, Brugada R, Brugada J. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 2005;112:279-92; discussion 279-92. 12. Priori SG, Napolitano C. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 2005;112:279-92; discussion 279-92. 13. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/ American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 2006; 27:2099-140.

Singapore Med J 2011; 52(9) : 651 SINGAPORE MEDICAL COUNCIL CATEGORY 3B CME PROGRAMME Multiple Choice Questions (Code SMJ 201109A) Question 1. Regarding the clinical presentation of myocardial infarction: (a) It can present with atypical chest pain. (b) Index of suspicion should be high in a middle-aged man with risk factors. (c) ECG changes of ischaemia occur early on in the clinical course. (d) Rise in cardiac enzymes occur within the first 1 2 hours. Question 2. Regarding ST elevation on ECG: (a) It can only be due to acute myocardial infarction. (b) It can also be seen in Brugada syndrome. (c) It should not extend beyond V3 in Brugada syndrome alone. (d) The association with reciprocal changes are strongly suggestive of acute myocardial infarction. Question 3. Regarding Brugada ECG pattern: (a) There are three patterns described. (b) Only Type 1 pattern is diagnostic and associated with sudden death. (c) Brugada ECG pattern with syncope or documented ventricular arrhythmias is an indication for ICD implant. (d) It is associated with higher risk in male patients and those with a family history of sudden death. Question 4. Regarding acute STEMI: (a) Early revascularisation is associated with lower mortality and better clinical outcomes. (b) Myocardial reperfusion can be achieved either by mechanical means (angioplasty) or pharmacological means (thrombolysis). (c) Involvement of the left anterior descending artery usually gives rise to ST elevation in the anterior leads V1 V3. (d) It is associated with isolated subendocardial myocardial injury. Question 5. Regarding Brugada syndrome: (a) All asymptomatic patients with any of the three different ECG patterns should undergo an electrophysiological study. (b) An ICD implant is currently the only consistently effective therapy in high-risk Brugada patients. (c) It is due to a mutation in the gene SCN5A in all cases. (d) Propensity toward ventricular arrhythmia is the result of electrical heterogeneity across the myocardial layers that may result from a loss-of-function mutation involving the fast sodium ion channels. True False Doctor s particulars: Name in full: MCR number: Specialty: Email address: SUBMISSION INSTRUCTIONS: (1) Log on at the SMJ website: http://www.sma.org.sg/cme/smj and select the appropriate set of questions. (2) Select your answers and provide your name, email address and MCR number. Click on Submit answers to submit. RESULTS: (1) Answers will be published in the SMJ November 2011 issue. (2) The MCR numbers of successful candidates will be posted online at www.sma.org.sg/cme/ smj by 24 October 2011. (3) All online submissions will receive an automatic email acknowledgment. (4) Passing mark is 60%. No mark will be deducted for incorrect answers. (5) The SMJ editorial office will submit the list of successful candidates to the Singapore Medical Council. Deadline for submission: (September 2011 SMJ 3B CME programme): 12 noon, 17 October 2011.